Connect Biopharma Holdings Ltd. (CNTB)
0.8354
-0.01
(-1.17%)
USD |
NASDAQ |
Oct 29, 16:00
0.803
-0.03
(-3.88%)
After-Hours: 20:00
Connect Biopharma Holdings Net Income (Quarterly) : -17.28M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.28M |
| March 31, 2026 | -19.40M |
| December 31, 2025 | -15.11M |
| Date | Value |
|---|---|
| September 30, 2025 | -17.20M |
| June 30, 2025 | -12.90M |
| March 31, 2025 | -10.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.768M |
| Total Expenses (Quarterly) | 20.05M |
| EPS Diluted (Quarterly) | -0.2749 |
| Enterprise Value | 21.72M |
| Profit Margin (Quarterly) | -624.4% |
| Earnings Yield | -143.2% |
| Normalized Earnings Yield | -143.18 |